[A trial of the use of Vasaprostan in patients with arteriosclerosis obliterans of the lower extremities].
Lebedev
L V
LV
Dobrynin
E V
EV
Luk'ianov
Iu V
IuV
Ignat'ev
E I
EI
Afonin
D N
DN
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000527:Alprostadil / Q000008:administration & dosage*; D001162:Arteriosclerosis Obliterans / Q000188:drug therapy* / Q000276:immunology / Q000503:physiopathology; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D007511:Ischemia / Q000188:drug therapy / Q000276:immunology / Q000503:physiopathology; D007866:Leg / Q000098:blood supply*; D008875:Middle Aged; D012074:Remission Induction
D000527:Alprostadil
Opyt primeneniia Vazaprostana u bol'nykh obliteriruiushchim aterosklerozom arteriĭ nizhnikh konechnosteĭ.